Raquel Perez-Lopez attended Medical School at the University of Barcelona and completed her specialty training in Radiology. She has completed a Masters in Clinical Sciences studying perfusion MRI in patients with high-grade astrocytoma. Supported by the ESR, a clinical fellowship then led her to the Royal London Hospital, followed by her move to the ICR and Royal Marsden, London (UK), where her PhD focused on the study of bone metastases by diffusion-weighted MRI.
These studies enabled her to identify the value of whole-body diffusion-weighted MRI as a prognostic and response biomarker of bone metastases in prostate which in turn led to the completion of the first prospective clinical trial in this context. Importantly, this work resulted in over fifteen manuscripts that she first or co-authored in prestigious titles including NEJM, Cell, Cancer Discovery, and Radiology.
Dr. Perez-Lopez joined VHIO in 2017 as PI of VHIO´s newly established Radiomics Group. Her research centers on functional imaging techniques and computational image analysis (radiomics) to better identify histological and molecular characteristics of tumors.